Rosetta Genomics (ROSG) Keeps Momentum Going, Indicated Much Higher Early
Tweet
Share
E-mailGet Alerts ROSG Hot Sheet
Join SI Premium – FREE
Rosetta Genomics (Nasdaq: ROSG) is headed for another strong open Tuesday after a late-session dip last Friday. Market data has the stock up about 13 percent in pre-market trading.
Last week, the company announced a $6 million registered direct offering as well as the appointment of a new finance chief.
Last week, the company announced a $6 million registered direct offering as well as the appointment of a new finance chief.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Sanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy
- Enphase Energy tumbles on guidance miss; BMO trims estimates and price target
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
